Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25239 | 22059453 | Aliment Pharmacol Ther | Caffeine is protective in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25240 | 22059109 | World J Hepatol | Role of ezetimibe in non-alcoholic fatty liver disease. | 2011 | Details |
| A25241 | 22056763 | Biochim Biophys Acta | Roles of PPARs in NAFLD: potential therapeutic targets. | 2011 | Details |
| A25243 | 22053378 | Zhonghua Gan Zang Bing Za Zhi | [The effects of curcumin derivative on experimental steatohepatitis]. | 2011 | Details |
| A25244 | 22051117 | FEBS J | New insights into the functions and localization of nuclear transglutaminase 2. | 2011 | Details |
| A25245 | 22050747 | Curr Med Chem | Fatty liver and ischemia/reperfusion: are there drugs able to mitigate injury? | 2011 | Details |
| A25246 | 22050199 | Aliment Pharmacol Ther | Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis. | 2011 | Details |
| A25247 | 22047200 | J Invest Surg | Type of steatosis influences microcirculation and fibrogenesis in different rat strains. | 2011 | Details |
| A25248 | 22046322 | PLoS One | Protective effects of white button mushroom (Agaricus bisporus) against hepatic steatosis in ovariectomized mice as a model of postmenopausal women. | 2011 | Details |
| A25251 | 22045426 | Dis Markers | Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. | 2011 | Details |
| A25252 | 22043839 | Expert Opin Pharmacother | Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome. | 2011 | Details |
| A25253 | 22043827 | Expert Opin Pharmacother | Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions. | 2011 | Details |
| A25254 | 22040420 | Chin Med J (Engl) | Etiology and prevalence of abnormal serum alanine aminotransferase levels in a general population in Northeast China. | 2011 | Details |
| A25255 | 22030814 | Acta Cir Bras | Fructose and NAFLD: metabolic implications and models of induction in rats. | 2011 | Details |
| A25256 | 22037452 | Biochem Biophys Res Commun | 17β-Estradiol attenuates saturated fatty acid diet-induced liver injury in ovariectomized mice by up-regulating hepatic senescence marker protein-30. | 2011 | Details |
| A25257 | 22036053 | Hum Pathol | Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease. | 2011 | Details |
| A25258 | 22035383 | Hepatol Res | Histopathological characteristics of non-alcoholic fatty liver disease in children: Comparison with adult cases. | 2011 | Details |
| A25259 | 25346653 | Curr Pediatr Rev | Keratin 18, Apoptosis, and Liver Disease in Children. | 2011 | Details |
| A25260 | 22034200 | J Magn Reson Imaging | Liver diffusivity in healthy volunteers and patients with chronic liver disease: comparison of breathhold and free-breathing techniques. | 2011 | Details |
| A25261 | 22027586 | J Hepatol | Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. | 2011 | Details |
| A25262 | 22027584 | J Hepatol | Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. | 2011 | Details |
| A25263 | 22027576 | J Hepatol | The value of pre-operative magnetic resonance spectroscopy in the assessment of steatohepatitis in patients with colorectal liver metastasis. | 2011 | Details |
| A25264 | 22025886 | J Magn Reson Imaging | Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. | 2011 | Details |
| A25265 | 22024606 | Med Princ Pract | Nonalcoholic fatty liver disease of two ethnic groups in Kuwait: comparison of prevalence and risk factors. | 2011 | Details |
| A25266 | 22024495 | Nutr Res | Adverse metabolic effects of a hypercaloric, high-fat diet in rodents precede observable changes in body weight. | 2011 | Details |
| A25267 | 22024083 | Hepatogastroenterology | Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitus. | 2012 | Details |
| A25268 | 22024080 | Hepatogastroenterology | Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A25269 | 22024078 | Hepatogastroenterology | Upregulation of Nrf2 expression in non-alcoholic fatty liver and steatohepatitis. | 2012 | Details |
| A25270 | 22023985 | J Hepatol | Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2011 | Details |
| A25271 | 22022213 | Int J Med Sci | Overexpression of CD36 and acyl-CoA synthetases FATP2, FATP4 and ACSL1 increases fatty acid uptake in human hepatoma cells. | 2011 | Details |
| A25272 | 22020821 | Hepatol Int | Non-alcoholic fatty liver disease: is iron relevant? | 2011 | Details |
| A25273 | 22018861 | Br J Nutr | Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis. | 2011 | Details |
| A25274 | 22017010 | Zhong Yao Cai | [Effect of soothing liver and invigorating spleen recipes on SREBP-1c mRNA and protein expression in hepatic tissues of rats with non-alcoholic fatty liver disease]. | 2011 | Details |
| A25275 | 22015962 | J Hepatol | A lipid to treat non-alcoholic fatty liver disease - the dawn of 'lipo-rehabilitation'? | 2011 | Details |
| A25276 | 22015687 | Clin Biochem | Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitis. | 2011 | Details |
| A25277 | 22014765 | Diabetes Res Clin Pract | Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C. | 2011 | Details |
| A25278 | 22013810 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [The key target of Chinese medicine treatment on alcoholic and nonalcoholic fatty liver disease: the gut]. | 2011 | Details |
| A25279 | 22013734 | Eur Rev Med Pharmacol Sci | Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. | 2011 | Details |
| A25280 | 22013501 | World J Diabetes | MicroRNAs in hepatic pathophysiology in diabetes. | 2011 | Details |
| A25281 | 22011249 | DNA Cell Biol | Association of genetic polymorphisms of glutathione-S-transferase genes (GSTT1, GSTM1, and GSTP1) and susceptibility to nonalcoholic fatty liver disease in Zahedan, Southeast Iran. | 2011 | Details |
| A25282 | 22008893 | Am J Gastroenterol | Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma. | 2011 | Details |
| A25283 | 22008843 | Food Funct | The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. | 2011 | Details |
| A25284 | 22002020 | Curr Opin Lipidol | Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic. | 2011 | Details |
| A25285 | 21999619 | Biomarkers | Erythrocyte antioxidant defenses as a potential biomarker of liver mitochondrial status in different oxidative conditions. | 2011 | Details |
| A25286 | 21999238 | J Agric Food Chem | Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro. | 2011 | Details |
| A25287 | 21994008 | Hepatology | Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. | 2012 | Details |
| A25288 | 21991518 | ISRN Gastroenterol | Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. | 2011 | Details |
| A25289 | 21991504 | ISRN Gastroenterol | Prevalence of NAFLD in Healthy and Young Male Individuals. | 2011 | Details |
| A25290 | 21990953 | World J Gastroenterol | Potential risk factors for nonalcoholic steatohepatitis related to pancreatic secretions following pancreaticoduodenectomy. | 2011 | Details |
| A25291 | 21990946 | World J Gastroenterol | Betaine and nonalcoholic steatohepatitis: back to the future? | 2011 | Details |
| A25292 | 21989716 | Mol Cell Biochem | Ω3-Polyunsaturated fatty acids prevent lipoperoxidation, modulate antioxidant enzymes, and reduce lipid content but do not alter glycogen metabolism in the livers of diabetic rats fed on a high fat thermolyzed diet. | 2011 | Details |
| A25293 | 21988593 | Diabet Med | Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities. | 2012 | Details |
| A25294 | 21987620 | World J Gastroenterol | JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. | 2011 | Details |
| A25295 | 21987619 | World J Gastroenterol | Spleen: A new role for an old player? | 2011 | Details |
| A25296 | 21987488 | Hepatology | Ethnicity and nonalcoholic fatty liver disease. | 2012 | Details |
| A25297 | 21987293 | Hepatology | Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. | 2011 | Details |
| A25298 | 21986673 | Eur J Nutr | Dietary supplementation of herring roe and milt enhances hepatic fatty acid catabolism in female mice transgenic for hTNFα. | 2011 | Details |
| A25299 | 21986643 | Curr Opin Lipidol | Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: an update. | 2011 | Details |
| A25300 | 21986524 | Biochem Biophys Res Commun | High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis. | 2011 | Details |
| A25301 | 21986124 | J Int Med Res | The role of hepatic liver X receptor α- and sterol regulatory element binding protein-1c-mediated lipid disorder in the pathogenesis of non-alcoholic steatohepatitis in rats. | 2011 | Details |
| A25302 | 21985374 | Clin Exp Immunol | Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease. | 2011 | Details |
| A25303 | 21983927 | J Gastroenterol | Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal. | 2011 | Details |
| A25304 | 21983427 | Toxicol Appl Pharmacol | Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice. | 2011 | Details |
| A25305 | 21983273 | Biochim Biophys Acta | Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice. | 2011 | Details |
| A25306 | 21981787 | Aliment Pharmacol Ther | The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. | 2011 | Details |
| A25307 | 21977865 | J Tradit Chin Med | Effects of yinchenhao decoction (see text) for non-alcoholic steatohepatitis in rats and study of the mechanism. | 2011 | Details |
| A25309 | 21971896 | Sao Paulo Med J | Steatosis of indeterminate cause in a pediatric group: is it a primary mitochondrial hepatopathy? | 2011 | Details |
| A25312 | 21967816 | Am J Pathol | Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in A×B mice. | 2011 | Details |
| A25313 | 21964711 | Front Med | Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities. | 2011 | Details |
| A25315 | 21963564 | Biochim Biophys Acta | Liver triacylglycerol lipases. | 2011 | Details |
| A25316 | 21963507 | Biol Pharm Bull | meso-Dihydroguaiaretic acid inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in human HepG2 cells. | 2011 | Details |
| A25317 | 21962038 | BMC Public Health | Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. | 2011 | Details |
| A25318 | 21960993 | Exp Diabetes Res | Predictors of impaired glucose regulation in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25319 | 21958877 | Eur J Pharmacol | Metformin regulates hepatic lipid metabolism through activating AMP-activated protein kinase and inducing ATGL in laying hens. | 2011 | Details |
| A25320 | 21958082 | Clin Transplant | Implications of worse renal dysfunction and medical comorbidities in patients with NASH undergoing liver transplant evaluation: impact on MELD and more. | 2011 | Details |
| A25321 | 21957486 | PLoS One | GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy. | 2011 | Details |
| A25322 | 21957160 | Am J Physiol Regul Integr Comp Physiol | Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. | 2011 | Details |
| A25323 | 21956711 | Diabetologia | Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial. | 2011 | Details |
| A25325 | 21954411 | World J Hepatol | Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis. | 2011 | Details |
| A25326 | 21953798 | Diabetes Care | Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa Heart Study. | 2011 | Details |
| A25327 | 21953442 | Hepatology | Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25328 | 21953137 | Dig Dis Sci | Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. | 2011 | Details |
| A25330 | 21952989 | Hepatology | "Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country. | 2011 | Details |
| A25331 | 21952703 | Arq Gastroenterol | Gluco-lipidic indices in treated hypothyroidism associated with nonalcoholic fatty liver disease. | 2012 | Details |
| A25332 | 21952702 | Arq Gastroenterol | Analysis of the sustained virological response in patients with chronic hepatitis C and liver steatosis. | 2012 | Details |
| A25333 | 21951922 | Hepatol Res | Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label, pilot study. | 2011 | Details |
| A25334 | 21951869 | Hepatol Res | Clinicopathological features of non-alcoholic fatty liver disease. | 2011 | Details |
| A25335 | 21950746 | J Gastroenterol Hepatol | Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. | 2011 | Details |
| A25336 | 21949781 | PLoS One | Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study. | 2011 | Details |
| A25337 | 21948570 | Turk J Gastroenterol | A new risk factor for the development of non-alcoholic fatty liver disease: HLA complex genes. | 2011 | Details |
| A25338 | 21948338 | Dig Dis Sci | Activation of liver X receptors attenuates endotoxin-induced liver injury in mice with nonalcoholic fatty liver disease. | 2011 | Details |
| A25339 | 21948267 | Obes Surg | Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery. | 2011 | Details |
| A25341 | 21947639 | Nutr Clin Pract | Nonalcoholic fatty liver disease: a review of the spectrum of disease, diagnosis, and therapy. | 2011 | Details |
| A25342 | 21946918 | Mol Med Rep | Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet. | 2011 | Details |
| A25343 | 21946149 | Exp Mol Pathol | Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis. | 2011 | Details |
| A25345 | 21943357 | Nutr Metab (Lond) | The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats. | 2011 | Details |
| A25347 | 21940337 | Hepatogastroenterology | Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism of hepatic leptin resistance in NAFLD. | 2011 | Details |
| A25348 | 21940261 | Adv Med Sci | Ultrastructure of liver progenitor/oval cells in children with nonalcoholic steatohepatitis. | 2011 | Details |
| A25349 | 21939732 | Mol Cell Endocrinol | PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population. | 2011 | Details |
| A25350 | 21937392 | Hepatogastroenterology | The clinical significance of HbA1c as a predictive factor for abnormal postprandial glucose metabolism in NAFLD patients with an elevated liver chemistry. | 2012 | Details |